2004
DOI: 10.1007/s10616-004-5125-1
|View full text |Cite
|
Sign up to set email alerts
|

Immortalized cells as experimental models to study cancer

Abstract: The development of cancer is a multi-step process in which normal cells sustain a series of genetic alterations that together program the malignant phenotype. Much of our knowledge of cancer biology results from the detailed study of specimens and cell lines derived from patient tumors. While these approaches continue to yield critical information regarding the identity, number, and types of alterations found in human tumors, further progress in understanding the molecular basis of malignant transformation dep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 100 publications
(144 reference statements)
0
16
0
Order By: Relevance
“…4 Moreover, the genetic changes required to establish continuous cell lines from normal cells recapitulate many of the genetic changes occurring in cancer. 5,6 These genetic changes are required to overcome replicative senescence, in which normal cells continue to be metabolically active but are restricted from further division.…”
Section: Cell Lines As Model Systemsmentioning
confidence: 99%
See 1 more Smart Citation
“…4 Moreover, the genetic changes required to establish continuous cell lines from normal cells recapitulate many of the genetic changes occurring in cancer. 5,6 These genetic changes are required to overcome replicative senescence, in which normal cells continue to be metabolically active but are restricted from further division.…”
Section: Cell Lines As Model Systemsmentioning
confidence: 99%
“…4 Moreover, the genetic changes required to establish continuous cell lines from normal cells recapitulate many of the genetic changes occurring in cancer. 5,6 These genetic changes are required to overcome replicative senescence, in which normal cells continue to be metabolically active but are restricted from further division. 1 Cells able to overcome senescence continue proliferating until their telomeres become so short that the chromosomes undergo fusion-breakage-bridge cycles and the ensuing genomic instability results in culture crisis.…”
Section: Cell Lines As Model Systemsmentioning
confidence: 99%
“…The glycoprotein interferon has been used for the treatment of a variety of conditions including hepatitis B and C [17], cervical intraepithelial neoplasia [18], cutaneous squamous neoplasia [19] and as off-label treatment of OSSN [20][21][22][23]. Interferon is an immuno modulator that consists of 165 amino acid residues, with arginine in position 23 [24].…”
Section: Ifn-α 2bmentioning
confidence: 99%
“…All lesions showed reduction in size, with 72% of cases showing complete resolution. Topical IFN-α 2b is normally given off-label four times a day for 3-4 months [20,22,23] and needs compounding and refrigeration. With intralesional interferon, there is no need for compounding, it is widely available, compliance is ensured and a more rapid resolution is observed with a median resolution time between 1.4 [30] and 1.1 months [21].…”
Section: Ifn-α 2bmentioning
confidence: 99%
“…The lack of mTERT-mediated immortalization in well-differentiated mouse cells might be due to the intrinsically higher level of TERT expression in mouse compared with human cells, the delivery method of the TERT gene, or cell line variability (7,19,29).…”
Section: Epithelial; Polycysticmentioning
confidence: 99%